Skip to main content
. 2023 Dec 19;15(3):1150–1158. doi: 10.1039/d3sc06357g

Fig. 1. Schematics of (a) the conventional heterogeneous ECL pathway and (b) the enhanced ‘redox mediated’ pathway in a heterogeneous bead-based immunoassay. The magnetic microbead is represented by the orange sphere while the [Ru(bpy)3]2+ luminophore and the [Ir(sppy)3]3− complex are labelled as Ru2+ and Ir3−, respectively.

Fig. 1